Using transgenic mice specifically lacking the PTEN gene in endothelial cells, Dr. Akira Suzuki and colleagues demonstrate that PTEN is required for normal cardiovascular development and that its loss enhanced tumor angiogenesis.
To be published in the September 1 issue of G&D, this new data suggests that PTEN regulates vascular growth factor (VGF) signaling to modulate cardiovascular development and post-natal neovascularization. Loss of PTEN in murine endothelial cells results is dysregulated VGF signaling, enhanced angiogenesis, and accelerated tumor growth.
Their results suggest that an individual who inherits a mutated PTEN allele, such as Cowden disease patient, is not only at risk for additional tumorigenic mutations, but may also experience accelerated growth of tumors due to enhanced angiogenesis. Moreover, the PTEN/PI3K pathway in endothelial cells is an attractive therapeutic target for the treatment of various malignancies.
Heather Cosel | Source: EurekAlert!
Further information: www.cshl.edu
More articles from
Life Sciences:
Genetic Biobanks: Deposits, Withdrawals, and Consumer Protection
21.11.2008 | Genetics and Public Policy Center
Research Consortium to Sequence Turkey Genome
21.11.2008 | Virginia Tech (Virginia Polytechnic Institute and State University)
Sustainable garden roofs developed as a new construction material
21.11.2008 | Studies and Analyses
Bees declared the winners in Earthwatch’s ‘irreplaceable species’ battle
21.11.2008 | Ecology, The Environment and Conservation
Hairspray is linked to common genital birth defect
21.11.2008 | Studies and Analyses
The Automobile – The Transition from Energy Guzzler to Power Supplier
20.11.2008 | Event News
Ministers meet to define the role of space in delivering global objectives
18.11.2008 | Event News
156th Annual Acoustical Society of America (ASA) Meeting in Miami
28.10.2008 | Event News